NCT07123402View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

April 20, 2026

Study Completion Date

May 27, 2026

Conditions
Chronic Postoperative Neuralgia
Interventions
DRUG

TRD205 tablets

orally ;Take TRD205 1 tablets and Placebo 2 tablets

DRUG

TRD205 tablets

orally ;Take TRD205 2 tablets and Placebo 1 tablets

DRUG

TRD205 tablets

orally ;Take TRD205 3 tablets and Placebo 0 tablets

DRUG

Placebo

orally ;Take Placebo 3 tablets

Trial Locations (1)

Unknown

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

lead

Beijing Tide Pharmaceutical Co., Ltd

INDUSTRY